Biology and pharmacology of Aging and Longevity (BPVL)

The Biology and Pharmacology of Aging and Longevity program aims to understand the mechanisms of aging through a multidisciplinary approach, ranging from normal aging to associated pathological processes and its societal impact.  Our program addresses the fundamental concepts of cellular aging and its effects on organs, organisms, and individuals. It provides an in-depth understanding of vulnerability to age-related disease, the biological mechanisms underlying the aging process, and therapeutic interventions aimed at improving quality of life and promoting healthy aging. The mission of the Biology and Pharmacology of Aging and Longevity program is to train the next generation of outstanding scientists interested in basic and translational research, entrepreneurs, and professionals in the field of aging biology who possess the skills and competencies necessary to work effectively in various international multi/interdisciplinary academic and private environments.

Language of instruction

• Master 1 (English/French) : Courses titled in English will be taught in English. 
• Master 2 (Anglais) : Courses titled in English will be taught in English (some courses will be part of the Erasmus Mundus Joint Master in Biology of Aging).

Applications

Applications on the e-candidat platform will be open from March 26th through June 11th, 2026.

All candidates from this list of countries must apply via Etudes en France, unless you currently reside in a EU country.

Keywords

Aging - Longevity - Cellular stress - Inflammation - Metabolism - Cell death - Epigenetics - Age-related diseases - Resilience - Repair - Regeneration - Stem cells - Senolytics - Senomodulators - Biotherapies.